Cargando…

Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters

Objective: The role of the tumor microenvironment in tumor progression and treatment response is being investigated for different types of cancer. This study aimed to determine the relationships between tumor microenvironment, histopathology, 18F-fluorodeoxyglucose positron emission tomography/compu...

Descripción completa

Detalles Bibliográficos
Autores principales: Soyluoglu, Selin, Tastekin, Ebru, Andac, Burak, Korkmaz, Ulku, Orun, Seyma Gizem, Durmus Altun, Gulay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556374/
https://www.ncbi.nlm.nih.gov/pubmed/37809246
http://dx.doi.org/10.7759/cureus.44751
_version_ 1785116859965636608
author Soyluoglu, Selin
Tastekin, Ebru
Andac, Burak
Korkmaz, Ulku
Orun, Seyma Gizem
Durmus Altun, Gulay
author_facet Soyluoglu, Selin
Tastekin, Ebru
Andac, Burak
Korkmaz, Ulku
Orun, Seyma Gizem
Durmus Altun, Gulay
author_sort Soyluoglu, Selin
collection PubMed
description Objective: The role of the tumor microenvironment in tumor progression and treatment response is being investigated for different types of cancer. This study aimed to determine the relationships between tumor microenvironment, histopathology, 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)-based metabolic parameters, treatment response, and overall survival (OS) in metastatic differentiated thyroid cancer (DTC).  Methods: Metastatic DTC patients who underwent 18F-FDG PET/CT between 2015-2019 were evaluated. Clinicopathological, histopathological features and PET/CT parameters of patients were recorded. Microenvironmental characteristics of the primary tumor, such as mitosis, intratumoral and peritumoral lymphocytosis, intratumoral and peritumoral fibrosis, were evaluated from the tissue samples. The relationships between these factors were statistically analyzed. Results: Sixty-five patients (38 females, 27 males, age: 49±15 years) were included. Mitosis, intra/peritumoral lymphocytosis, and intra/peritumoral fibrosis were frequent; however, none of them had a statistically significant association with PET-positive metastases, treatment response, or OS. Univariate analysis showed that gender, size, thyroglobulin values, residual thyroid tissue, PET-positive metastases, and maximum standardized uptake value (SUVmax) were significant predictors of OS. At multivariate analysis, PET-positive metastases (HR=-2.65, 95%CI 0.007−0.707, p=0.024) and SUVmax (HR=-2.74, 95%CI 0.006−0.687, p=0.023) were the only independent predictors for OS.  Conclusion: Our study revealed that microenvironmental characteristics of the primary tumor did not show prognostic significance in metastatic DTC. PET-positive metastases and SUVmax levels were the only significant factors that predicted overall survival in DTC. Supporting the results of our study with further studies with a larger sample size may be necessary to determine the relationship between the tumor microenvironment and prognosis in DTC.
format Online
Article
Text
id pubmed-10556374
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-105563742023-10-07 Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters Soyluoglu, Selin Tastekin, Ebru Andac, Burak Korkmaz, Ulku Orun, Seyma Gizem Durmus Altun, Gulay Cureus Endocrinology/Diabetes/Metabolism Objective: The role of the tumor microenvironment in tumor progression and treatment response is being investigated for different types of cancer. This study aimed to determine the relationships between tumor microenvironment, histopathology, 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)-based metabolic parameters, treatment response, and overall survival (OS) in metastatic differentiated thyroid cancer (DTC).  Methods: Metastatic DTC patients who underwent 18F-FDG PET/CT between 2015-2019 were evaluated. Clinicopathological, histopathological features and PET/CT parameters of patients were recorded. Microenvironmental characteristics of the primary tumor, such as mitosis, intratumoral and peritumoral lymphocytosis, intratumoral and peritumoral fibrosis, were evaluated from the tissue samples. The relationships between these factors were statistically analyzed. Results: Sixty-five patients (38 females, 27 males, age: 49±15 years) were included. Mitosis, intra/peritumoral lymphocytosis, and intra/peritumoral fibrosis were frequent; however, none of them had a statistically significant association with PET-positive metastases, treatment response, or OS. Univariate analysis showed that gender, size, thyroglobulin values, residual thyroid tissue, PET-positive metastases, and maximum standardized uptake value (SUVmax) were significant predictors of OS. At multivariate analysis, PET-positive metastases (HR=-2.65, 95%CI 0.007−0.707, p=0.024) and SUVmax (HR=-2.74, 95%CI 0.006−0.687, p=0.023) were the only independent predictors for OS.  Conclusion: Our study revealed that microenvironmental characteristics of the primary tumor did not show prognostic significance in metastatic DTC. PET-positive metastases and SUVmax levels were the only significant factors that predicted overall survival in DTC. Supporting the results of our study with further studies with a larger sample size may be necessary to determine the relationship between the tumor microenvironment and prognosis in DTC. Cureus 2023-09-05 /pmc/articles/PMC10556374/ /pubmed/37809246 http://dx.doi.org/10.7759/cureus.44751 Text en Copyright © 2023, Soyluoglu et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Soyluoglu, Selin
Tastekin, Ebru
Andac, Burak
Korkmaz, Ulku
Orun, Seyma Gizem
Durmus Altun, Gulay
Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters
title Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters
title_full Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters
title_fullStr Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters
title_full_unstemmed Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters
title_short Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters
title_sort tumor microenvironment features as predictive biomarkers in metastatic differentiated thyroid cancer and their relationship with 18f-fluorodeoxyglucose positron emission tomography/computed tomography (18f-fdg pet/ct) metabolic parameters
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556374/
https://www.ncbi.nlm.nih.gov/pubmed/37809246
http://dx.doi.org/10.7759/cureus.44751
work_keys_str_mv AT soyluogluselin tumormicroenvironmentfeaturesaspredictivebiomarkersinmetastaticdifferentiatedthyroidcancerandtheirrelationshipwith18ffluorodeoxyglucosepositronemissiontomographycomputedtomography18ffdgpetctmetabolicparameters
AT tastekinebru tumormicroenvironmentfeaturesaspredictivebiomarkersinmetastaticdifferentiatedthyroidcancerandtheirrelationshipwith18ffluorodeoxyglucosepositronemissiontomographycomputedtomography18ffdgpetctmetabolicparameters
AT andacburak tumormicroenvironmentfeaturesaspredictivebiomarkersinmetastaticdifferentiatedthyroidcancerandtheirrelationshipwith18ffluorodeoxyglucosepositronemissiontomographycomputedtomography18ffdgpetctmetabolicparameters
AT korkmazulku tumormicroenvironmentfeaturesaspredictivebiomarkersinmetastaticdifferentiatedthyroidcancerandtheirrelationshipwith18ffluorodeoxyglucosepositronemissiontomographycomputedtomography18ffdgpetctmetabolicparameters
AT orunseymagizem tumormicroenvironmentfeaturesaspredictivebiomarkersinmetastaticdifferentiatedthyroidcancerandtheirrelationshipwith18ffluorodeoxyglucosepositronemissiontomographycomputedtomography18ffdgpetctmetabolicparameters
AT durmusaltungulay tumormicroenvironmentfeaturesaspredictivebiomarkersinmetastaticdifferentiatedthyroidcancerandtheirrelationshipwith18ffluorodeoxyglucosepositronemissiontomographycomputedtomography18ffdgpetctmetabolicparameters